Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related TEVA
Earnings Scheduled For July 30, 2015
Eagle Pharma Targets Hiked At Piper Jaffray On 'Room For Value Creation'
IBD 50: 10 Top Stocks Reporting Earnings This Week (Investor's Business Daily)
Related QEP
How To Profit From Low Oil Prices: An Energy Takeout Targets Portfolio
6 'Select' Energy Stocks Imperial Loves
Should You Sell QEP Resources (QEP) Before Earnings? - Tale of the Tape (Zacks)

Analysts at JP Morgan downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “overweight” to “neutral.” The target price for Teva has been lowered from $45 to $43. Teva's shares closed at $38.88 yesterday.

Deutsche Bank downgraded QEP Resources (NYSE: QEP) from “buy” to “hold.” The target price for QEP Resources has been lowered from $37 to $34. QEP Resources' shares closed at $28.78 yesterday.

Baird downgraded Brady (NYSE: BRC) from “outperform” to “neutral.” The target price for Brady has been lowered from $41 to $33. Brady's shares closed at $30.52 yesterday.

Analysts at DA Davidson downgraded Under Armour (NYSE: UA) from “buy” to “neutral.” Under Armour's shares closed at $80.59 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Jul 2015Leerink SwannMaintainsOutperform
Jul 2015Morgan StanleyResumesOverweight
Jul 2015BMO CapitalUpgradesMarket PerformOutperform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BRC + QEP)

Get Benzinga's Newsletters